Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma

We explored the hypothesis that sorafenib may improve the effect of transarterial chemoembolization (TACE) in patients with recurrent hepatocellular carcinoma (HCC) and that longer sorafenib duration was associated with additional survival benefits. In this retrospective, nested case-controlled stud...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Wan, Xuying, Zhai, Xiaofeng, Yan, Zhenlin, Yang, Pinghua, Li, Jun, Wu, Dong, Wang, Kui, Xia, Yong, Shen, Feng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Clinical Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347807/
https://ncbi.nlm.nih.gov/pubmed/27566566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11514
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia